Sort
21,453 grants matching “tuberculosis”
SBIR Phase II: A Rapid Foodborne Pathogen Analyzer
$695,521Stuart Farquharson · Real-Time Analyzers, Incorporated · · FY2013 · TIP
TB Aftermath
$695,483Jonathan E Golub · Johns Hopkins University · R01 · FY2020 · AI
Human-centered Design and Communities of Practice to Improve Delivery of Home-based TB Contact Investigation in Uganda
$695,368John Lucian Davis · Yale University · R01 · FY2021 · AI
Chlamydial Vaccine Testing in Mice and Guinea Pigs
$695,230Nilu Goonetilleke · Univ Of North Carolina Chapel Hill · U19 · FY2023 · AI
Modulation of epigenetic programming of tissue resident macrophage lineages to impact HIV-1 infection, maintenance, and persistence.
$695,223David G Russell · Cornell University · R01 · FY2023 · AI
Innate immune response of LTBI+HIV+ children
$695,140Ramakrishna Vankayalapati · University Of Texas Hlth Ctr At Tyler · R01 · FY2021 · AI
Innate immune response of LTBI+HIV+ children
$695,140Ramakrishna Vankayalapati · University Of Texas Hlth Ctr At Tyler · R01 · FY2022 · AI
Necrosis in Pulmonary TB granulomas: dynamics, mechanisms, and therapies
$695,103Igor Kramnik · Boston University Medical Campus · R01 · FY2023 · HL
T Cell Memory to Pathogens: Generation and Function
$695,076Susan L Swain · Univ Of Massachusetts Med Sch Worcester · P01 · FY2011 · AI
Clinical And Therapeutic Studies Of Human Filariasis and Related Diseases
$695,042Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Longitudinal Study of HIV and Aging in Brazil
$694,692Jessica L Castilho · Vanderbilt University Medical Center · R01 · FY2023 · AG
Tuberculosis and T cell Recognition
$694,621Samuel M Behar · Univ Of Massachusetts Med Sch Worcester · R01 · FY2018 · AI
MAGNETIC RESONNANCE CTR: PROTEIN STRUCT, TUBERCULOSIS, MOLEC PROBE SYNT
$694,575University Of California Los Angeles · C06 · FY2002 · RR
An Antigen-Detection Blood Test for Pulmonary Tuberculosis
$694,190Antonino None Catanzaro · University Of California, San Diego · R01 · FY2020 · AI
Centralized assay datasets for modelling support of small drug discovery organizations
$694,172Sean Ekins · Collaborations Pharmaceuticals, Inc. · R44 · FY2018 · GM
Studies of the Antibacterial Activity of and Resistance to Molecules Targeting the ClpP Peptidase
$694,153Jason K Sello · Brown University · R01 · FY2018 · AI
Regulation Of Immunopathology In Bacterial And Parasitic Disease
$693,953Alan Sher · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Aerobiology, immunology, and Mycobacterium tuberculosis transmission
$693,648David J. Horne · University Of Washington · R01 · FY2021 · AI
Investigation of synergy between Rifampin and SQ109, a new anti-TB drug candidate
$693,529Venkata M Reddy · Sequella, Inc. · R21 · FY2009 · AI
Translational approaches to improve understanding and outcome in Tuberculous meningitis
$693,318Martin Alfons Gengenbacher · Hackensack University Medical Center · R01 · FY2022 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$693,118Veda M Latin · Public Health Services · U52 · FY2007 · PS
Project 2: Response to Treatment
$693,087David R Sherman · Seattle Children'S Hospital · U19 · FY2020 · AI
Elucidating the path to type I IFNs in TB infection
$693,073Amy K Barczak · Massachusetts General Hospital · R01 · FY2024 · AI
PS05-003 TUBERCULOSIS ELIMINATION AND LABORATORY
$693,046Loren Robertson · Indiana State Department Of Health · U52 · FY2007 · PS
Mechanism Based Inhibition of M Tuberculosis Enzymes
$692,972John S Blanchard · Albert Einstein College Of Medicine · R01 · FY2006 · AI